Læknablaðið - 15.02.1990, Blaðsíða 14

90
LÆKNABLAÐIÐ
HEIMILDIR
1. Namboodiri KK, Kaplan EB, Heach I et al. The
collaborative lipid research clinics family study:
Biological and cultural determinants of familial
resemblance for plasma lipids and lipoproteins. Genet
Epidemiol 1985; 2: 227-54.
2. Sing CF, Orr JD. Analysis of genetic and
environmental sources of variation in serum
cholesterol in Tecumseh, Michigan. IV. Separation
of polygene from common environmental effects. Am
J Hum Genet 1985; 30: 491-504.
3. Keys A, Aravanis C, Blackbum HW et al.
Epidemiological studies related to coronary heart
disease. Characteristics of men aged 40-59 in seven
countries. Acta Med Scand 1967; 480: 1-392.
4. Shephard J, Packard CJ. Lipid transport through
the plasma: the metabolic basis of hyperlipidaemia.
Bailliére’s Clin Endocrin Metabol 1987; 1 (3): 495-
514.
5. Schaefer EJ, Levy RI. Pathogenesis and management
of lipoprotein disorders. N Engl J Med 1985; 312
(20); 1300-10.
6. Mahley RW, Hui DY, Irtnerarity TL, Weisgraber KH.
Two independent lipoprotein receptors on hepatic
membranes of dog, swine and man. Apo-B, E and
apo-E receptors. J Clin Invest 1981; 68: 1197-206.
7. Sigurdsson G, Nicoll A, Lewis B. Conversion of very
low density lipoprotein to low density lipoprotein.
A metabolic study of apolipoprotein-B kinetics in
human subjects. J Clin Invest 1975; 56: 1481.
8. Brown MS, Goldstein JL. A receptor-mediated
pathway for cholesterol homeostasis. Science 1986;
232; 34-47.
9. Zilversmit DB. Lipid transfer proteins. J Lipid
Research 1984; 25:1563-9.
10. Rifici VA, Eder HA. A hepatocyte receptor for HDL
specific for apolipoprotein AI. J Biolog Chem 1984;
259: 13814-18.
11. Miller NE. High-density lipoprotein: A major risk
factor for coronary atherosclerosis. Bailliére’s Clin
Endocrin Metabol 1987:1 (3): 603-22.
12. Wilson PWF, Robert DA, Castelli WP. High
density lipoprotein cholesterol and mortality. The
Framingham Heart Study. Arteriosclerosis 1988; 6
(6): 737-41.
13. Friedewald WT, Levy RI, Frederickson DS.
Estimation of the concentration of low-density
lipoprotein cholesterol in plasma without use of the
preparative ultracentrifuge. Clin Chem 1972; 18: 499-
502.
14. Bachorik PS, Kwiterovich PO. Apolipoprotein
measurements in clinical biochemistry and their
utility vis-a-vis conventional assays. Clinica Chimica
Acta 1988; 178; 1-34.
15. Naito HK. The significance of apolipoprotein
measurements. J Clin Immunoassay 1986; 9(1); 11-
20.
16. Utermann G. Apolipoprotein E polymorphism in
health and disease. Am Heart J 1987; 113 (2); 433-
40.
17. Sigurdsson G, Utermann G. Effect of genetic
polymorphism of apolipoprotein (apo)-E on serum
cholesterol levels in an Icelandic and German
population. Urdráttur: Ráðstefna um rannsóknir í
Læknadeild H.í. 1988.
18. Ehnholm C, Matti L, Kuusi T, Nikkilá E, Utermann
G. Apolipoprotein E polymorphism in the Finnish
population: gene frequencies and relation to
lipoprotein concentrations. J Lipid Research 1986;
27: 227-35.
19. Boerwinkle E, Sing CF. Bias of the contribution of
single-locus effects to the variance of a quantitative
trait. Am J Hum Genet 1986; 39: 137-44.
20. Menzel H-J, Utermann G. Apolipoprotein E
phenotyping from serum by Westem blotting.
Electrophoresis 1986; 7: 492-5.
21. Sing CF, Davignon J. Role of the apolipoprotein E
polymorphism in determining normal plasma lipid
and lipoprotein variation. Am J Hum Genet 1985; 37:
268-85.
22. Davignon J, Gregg RE, Sing CF. Apolipoprotein E
polymorphism and atherosclerosis. Arteriosclerosis
1988; 8: 1-21.
23. Getz GS, Mazzone T, Soltys P, Bates SR.
Atherosclerosis and apoprotein E. An enigmatic
relationship. Arch Pathol Lab Med 1988; 112: 1048-
55.
24. Mahley RW. The molecular basis of atherosclerosis:
concepts derived from studies of lipoprotein
metabolism and cell biology. Clin Invest Med 1988; 9
(4): 304-8.
25. Funke H, Rust S, Assmann G. Detection of
apolipoprotein E variants by an oligonucleotide
»melting« procedure. Clin Chem 1986; 32 (7): 1285-
9.
26. Miiller D. Xanthomata hypercholesterolemia, angina
pectoris. Acta Med Scand 1938; 89 (suppl); 75-84.
27. Goldstein JL, Brown MS. Familial
hypercholesterolemia: identification of a defect in the
regulation of 3-hydroxy-3-methylglutaryl coenzyme.
A reductase activity associated with overproduction
of cholesterol. Proc Natl Acad Sci USA 1973; 70:
2804-8.
28. Goldstein JL, Brown MS. The metabolic basis of
inherited disease. JB Stanbury et al, (eds) McGraw-
Hill, New York, 1983, 672-712.
29. Jenkins T, Nicholls E, Gordon E, Mendelsohn
D, Seftel HC, Andrew MJA. Familial
hypercholesterolaemia - a common genetic disorder
in the Afrikaans population. S Afr Med J 1980; 57:
943-7.
30. Slack J. Inheritance of familial hypercholesterolemia.
Atheroscler Rev 1979; 5: 35-66.
31. Goldstein JL, Schrott HG, Hazzard WR, Bierman
EL, Motulsky AG. Hyperlipidemia in coronary heart
disease. II. Genetic analysis of lipid levels in 176
families and delineation of a new inherited disorder,
combined hyperlipidemia. J Clin Invest 1973; 52:
1544-68.
32. Gudmundsson S, Thorgeirsson G, Thorsteinsson Th,
Sigfusson N, Sigurdsson G. Risk factor screening
amongst first degree relatives of patients with
myocardial infarction. Dan Med Bull 1983; 30: 259-
62.
33. Humphries S, Taylor R, Jeenah M, Seed M. The use
of recombinant DNA techniques for the diagnosis of
familial hypercholesterolaemia. J Inher Metab Dis
1988; 11: 33-44.
34. Tolleshaug H, Hobgood KK, Brown MS,
Goldstein JL. The LDL receptor locus in familial
hypercholesterolemia: Multiple mutations disrupt
transport and processing of a membrane receptor. Cell
1983;32:941-51.
35. Yamamoto T, Davis LG, Brown MS, Schneider WJ,
Casey ML, Goldstein JL, Russell DW. The human
LDL-receptor: a cysteine-rich protein with multiple
Alu sequences in its mRNA. Cell 1984; 39: 27-38.